chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shingles  I am a 54 year old male living in another country. I have developed shingles as diagnosed by my doctor on 17th May 2021. During night between 16th May and 17th May, I developed these shingles rashes.   I had first dose of Astrazeneca vaccine (called Covishield) on 14th April 2021. Nearly a month later I developed shingles. I am Type-2 diabetic for the last 20 years with excellent control and no organ damage so far. Still on 2500 mg metformin chloride per day and 10 mg Jardiance per day. I also have high cholesterol and high triglycerides since 15 years and I am on 10 mg Crestor a day. I also suffer from Hashimoto hypothyroidism (an auto immune condition) since 15 years and take about 70 mcg of levothyroxine a day. I am otherwise a fit person with regular exercise and a BMI of 20.5. I have been taking Vitamin C 500 mg for last 20 years, and regularly take Zinc and Vitamin D. Vitamin D level 60 ng/ml.  Looks like Covid vaccine induces shingles in people with auto immune disorder that was not thoroughly checked and studied due to urgent need of vaccine roll out. If stress reduces immunity and is the reason for eruption of shingles, I have been suffering stress from the last one year due to job loss and threat of job loss. But why Shingles erupted only after Covid vaccination? I should have suffered it earlier! It takes two weeks for covid vaccine to become active which could have caused body to fight it and thus lowering immunity. May be immunity is lowering more than necessary when compared to other vaccines. Advantage is taken by shingles virus due to this lowered immunity and causing shingles.  I have never suffered chickenpox during my entire life as I could have been vaccinated as a child for chickenpox. But I still got shingles now after Covid vaccination.   Four years ago, due to job requirements, I had to take multiple vaccinations such as rabies, etc. At the time I did not suffer shingles? But now only after Covid vaccination from Astrazeneca! Seems quick rollout of vaccine has created additional problems for certain groups of populations.  Luckily, I began treatment within 24 hrs with antiviral medication. My friend suffered from shingles 5 years ago. He complained about terrible shooting pain which is the case with shingles it seems. Surprisingly, so far I have not had any shooting pain, no itching, etc. A mild discomfort and a slight burning sensation on upper left chest, left back where shingles formed. But it shingles as confirmed by doctor. Covid vaccination is inducing new kind of shingles with less pain?
No appetite, dizzy, rash around chest and very tired for 4 weeks. No treatment, Advised to consult with his primary care provider.
This spontaneous case was reported by a consumer and describes the occurrence of ASYMPTOMATIC COVID-19 (tested positive for COVID-19 but no symptoms) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination. Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for Prophylactic vaccination. No Medical History information was reported. In March 2021, the patient received first dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (unknown route) 1 dosage form. In October 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). On 20-Dec-2021, the patient experienced ASYMPTOMATIC COVID-19 (tested positive for COVID-19 but no symptoms). In October 2021, INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) had resolved. At the time of the report, ASYMPTOMATIC COVID-19 (tested positive for COVID-19 but no symptoms) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Dec-2021, COVID-19: sars-cov-2 negative (Negative) SARS-CoV-2 Negative and sars-cov-2 positive (Positive) SARS-CoV-2 positive. No concomitant and treatment information was provided by the reporter. Company comment: This is a spontaneous case concerning a male patient of unknown age, with no reported medical history and Interchange of vaccine products (the patient received one dose of the JANSSEN COVID-19 VACCINE, 7 months prior), who experienced the non-serious unexpected, AESI of Asymptomatic COVID-19. The event occurred approximately 2 months after the booster dose of mRNA-1273 vaccine (second dose in the series since the first dose was JANSSEN COVID-19 VACCINE). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. Sender's Comments: This is a spontaneous case concerning a male patient of unknown age, with no reported medical history and Interchange of vaccine products (the patient received one dose of the JANSSEN COVID-19 VACCINE 7, months prior), who experienced the non-serious unexpected, AESI of Asymptomatic COVID-19. The event occurred approximately 2 months after the booster dose of mRNA-1273 vaccine (second dose in the series since the first dose was JANSSEN COVID-19 VACCINE). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
One week after first dose, injection site felt hard, swollen, and painful. Pt was unable to lift arm due to pain. Swelling and pain improved after 3 days then worsened again, with development of hives at injection site. Pt also reported headache that started at approximately same time, 1 week after first injection
swelling, redness and pain in the arm of injection; swelling, redness and pain in the arm of injection; swelling, redness and pain in the arm of injection; itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling, redness and pain in the arm of injection), VACCINATION SITE ERYTHEMA (swelling, redness and pain in the arm of injection), VACCINATION SITE PAIN (swelling, redness and pain in the arm of injection) and VACCINATION SITE PRURITUS (itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling, redness and pain in the arm of injection), VACCINATION SITE ERYTHEMA (swelling, redness and pain in the arm of injection), VACCINATION SITE PAIN (swelling, redness and pain in the arm of injection) and VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE SWELLING (swelling, redness and pain in the arm of injection), VACCINATION SITE ERYTHEMA (swelling, redness and pain in the arm of injection), VACCINATION SITE PAIN (swelling, redness and pain in the arm of injection) and VACCINATION SITE PRURITUS (itchy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Pt presented to office on 10/31/19 with Zoster Rash on same arm as receiving Varivax Immunization.
My Daughter was fine Saturday morning running around playing being a toddler...she.climbed on her Dads lap her head dropped and she.just started shaking.
Patient began to have red rash to bilateral arms, chest, back, and face 10 min. after administration of vaccines. Patient denied any difficulty breathing. BENADRYL 50mg/ml was administered IM to patients right glute 5 minutes after appearance of rash per orders of PA-C. Rash began to dissipate within 1-2 minutes of administration of BENADRYL. Education was provided by PA-C on administration of oral BENADRYL at home if rash persisted and that no further doses of these vaccines should be given to patient. Telephone number for Health Department was provided for family to contact if need arises.
7x7 cm red, circular, warm and tender to touch reaction on (R) deltoid. Swelling noted.
A nurse reported that a 76 year old male received an injection of Pnu-Imune 23 on 10/26/99 and developed an injection site reaction described as "cellulitis". He recovered. This is 1 of 2 reports from this facility of injection site reactions following receipt of Pnu-Imune 23.
On the morning of Feb 7th, 8 days after my first Moderna shot, I found a red ring on my arm, radius about an inch to an inch and a quarter, around the injection site.  It's slightly itchy, but mostly looks like I've had a patchy breakout in that circle.  At first it looked similar to the "bullseye" that they tell you to watch out for with lyme disease.  Throughout the morning, the red ring has filled in with patchy, very slightly raised red skin.  I googled it online and found it's called "Covid arm," and seems to be harmless, but I was encouraged by a friend in the medical field to fill out this report.  She thought it might benefit future research and that it could be a response connected to my eczema.
Torticollis within a few days of receiving the listed vaccines. Then regression of speech and eye contact, developmental delay and autism over the following months after receiving the listed vaccines.
Patient came in to the vaccination clinic for 1st dose of Pfizer vaccine. She initially marked in the questionnaire receiving a Moderna vaccine, when questioned about her choice she denied receiving it and received 1 dose of Pfizer as "1st dose". It was later confirmed that the patient did received a Moderna Vaccine on 2/17/2021.
Pt developed a hard red lump on her arm. She stated it began the day of the flu shot and has gotten progressively worse. It is painful all the way down to her fingertips. Advised pt to MD.
Itchy, painful rash all over body continues to be an ongoing problem 8 months later.
Muscle pain , swollen face, teeth hurting ,  jaw hurting, back of my ears are swollen and in pain, weakness,tiredness,Fever, chills, knees shaking when i try to walk
Patient stated she felt a node that formed on the left side of her collar bone about 2 hours after she received the vaccine on 5/16/21.  Patient received the vaccine in the left arm.  Patient stated the pain and size progressively increased. Patient called the pharmacy on 5/18/21 stating the node was about a quarter size and very painful. Patient was advised to contact her primary care doctor for further evaluation and to take some ibuprofen/Tylenol for pain.
(L) arm with 2 x 1 1/2 cm area of erythema & hyperpigmentation.
Felt lethargic; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Felt lethargic) and ARTHRALGIA (Joint pain) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No relevant medical history provided.  Concomitant products included MULTIVITAMIN & MINERAL for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced LETHARGY (Felt lethargic) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Joint pain and Lethargic, at an unspecified dose and frequency. On 13-Apr-2021, LETHARGY (Felt lethargic) and ARTHRALGIA (Joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-132381 (Patient Link).
Severe migraines; Hormone fluctuations; Brain fog; Muscle weakness; Night sweats; This is a spontaneous report from a contactable consumer, the patient. A 50-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 23Apr2021 at 11:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 25Mar2021 at 11:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 23:00 i.e. three days after the second dose, the patient experienced severe migraines, started experiencing night sweats, hormone fluctuations, brain fog and muscle weakness. This was still on going 10 days post vaccine. The clinical outcome of the events severe migraines, hormone fluctuations, brain fog, muscle weakness and night sweats were not recovered.   No follow-up attempts are needed. No further information is expected.
pt recvd vax & following each series, exp a prickly type rash around inject site (5-6cm diameter) & diarrhea for 1-2 days;
Complaints of bruising; seen in office on 9/8/03. Widespread petechiae and purpura in numerous areas. Diagnosed with thrombocytopenia. Question of idiopathic thrombocytopenia purpura. Adverse effect; measles vaccine. Treatment IV gammaglobulin with good response. The discharge statement states ITP.
None noted or known reaction. Received Tdap x 2 10/2/13 and 1/23/14.
No adverse event; Expired Vaccination Administed; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccination Administed) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7170B) for COVID-19 prophylaxis.     The patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.    On 15-May-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Jun-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .25 milliliter. On 20-Jun-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccination Administed). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccination Administed) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
This vaccine was given 3 dayS past the BUD (6/23/22).  Moderna was contacted and the lot was analyzed.  Per Moderna this lot was still active and the patient did not need to be revaccinated.
I do not feel well; heart has a burning sensation; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "I do not feel well"; BURNING SENSATION (non-serious), outcome "unknown", described as "heart has a burning sensation".  Additional information: Questionnaires included that the patient received the vaccine and he did not feel well. His heart had a burning sensation for a few weeks now. He requested that he need help because he had no money or good doctors.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever of 102° for 2+ days,  body aches, severe headache, extreme fatigue
developed a fever as high as 101.8; chills; This is a spontaneous report from a contactable pharmacist (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number/expiration date: EK9231), via intramuscular route of administration, on 23Dec2020 at 02:00 PM (at the age of 37 years old) as a single dose in the left arm for COVID-19 immunization. Relevant medical history was none. The patient did not have any known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Dec2020, at 03:00 PM, the patient developed a fever as high as 101.8 (no units provided) with no other symptoms beyond fever and chills. The patient did not take any anti-pyretics to treat the fever and her temperature came down on its own overnight. By the next day, she felt back to normal. No treatment was received for the events fever and chills. The outcome of the events fever and chills was recovered on 30Dec2020. Since the vaccination, the patient had been tested for COVID-19 (via saliva polymerase chain reaction [PCR]) with negative result.
Soreness at injection site; low grade fever; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (COMIRNATY), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1 , Manufacturer: Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 2, Manufacturer: Unknown), for COVID-19 Immunization; Covid-19 vaccine (Dose 3, Manufacturer: Unknown), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Soreness at injection site"; PYREXIA (non-serious), outcome "unknown", described as "low grade fever"; FATIGUE (non-serious), outcome "unknown". Relevant laboratory tests and procedures are available in the appropriate section. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information has been received from a nurse concerning a 4 year old male with AMOXIL allergy who on 31-JUL-2009 was vaccinated with a dose of VARIVAX (Merck).  Concomitant vaccinations included DTAP, POLIO virus vaccine and MMR.  On 20-AUG-2009 the patient developed maculopapular rash after receiving VARIVAX (Merck).  The patient had 5-6 lesions on his abdomen, arm, and hip.  At the time of reporting, the patient had not recovered.  The patient called the nurse.  Additional information has been requested.
Pt was given an expired vaccine.  Vaccine expired on 8.19.2022 and was given on 8.22.2022.  Pt did not have an adverse reactions at this time.  Vaccine was pulled from deep freeze on 6.10.2022 which made the vaccine expire on 8.19.22.
heart attack; This is a spontaneous report from a contactable consumer (patient).   A 67-year-old male patient received bnt162b2 (BNT162B2, lot # EL9263) at single dose at left arm on 23Jan2021 14:15 for Covid-19 immunisation.  Medical history included hypertension, high cholesterol. No known allergies. The patient had not experienced Covid-19 prior vaccination. There were no concomitant medications. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine.  On 24Jan2021 06:00, the morning after he received the COVID-19 vaccine, he had a heart attack. The patient was hospitalized for heart attack for 2 days and evet was considered life threatening. The doctor placed 2 stents in his arteries. The patient underwent lab tests and procedures which included Sars-cov-2 test: negative on 24Jan2021.
death E87.1 - Hyponatremia J18.9 - Pneumonia, unspecified organism E87.1 - Hypo-osmolality and hyponatremia D69.6 - Thrombocytopenia, unspecified
Two weeks after the flu shot, my left arm still aches as if the shot was just administered.  The pain has not gone away.
Presented to the emergency department from group home for evaluation fever, sleepiness and shortness of breath , COVID positive, COVID Pneumonia Tx, w/. Zinc. IV remdesivir
Low to moderate fever for approximately two days, after Moderna booster dose following two doses of Pfizer in March.  Also fairly significant pain at injection site upon touch. Both adverse events were mostly or entirely gone after 48 hours.
This spontaneous report as received from a healthcare worker refers to unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with unspecified doses of alternate doses (over one year between doses) of GARDASIL (dose, route, lot number and expiration date not reported). No adverse effects were noted. Additional information is not expected because the reporter refused additional contact.
Lymphadenopathy. Covid booster received in community on 12/30/2021 Left arm vaccine. Local swelling to left axillary lymph node. On PE on 1/11/22 showing left axilla with 1 in x 2.5 in swelling, erythematous swelling with 0.5 cm border of erythema around protruding swelling, painful to touch, no drainage
This is a spontaneous report from a cont actable consumer. A 21-year-old male patient received the second dose of TRUMENBA at 0.5 ml single dose on 13May2015 18:00, intramuscular on left arm for immunization. The patient experienced that his body went into shock because of low blood sugar, was delirious, he was cold, shivering, he was very sensitive, had flu like symptoms, nausea, his right leg was in a lot of pain and he could not walk on it, experienced appetite and thirst excessive and headache. The patient's sister received the first dose of the same vaccine at 18-year-old and experienced sick symptoms. The outcome of the events was reported as recovering.
Initial case was received on 22 September 2010 from a healthcare professional. A 36 year old male patient received on 21 September 2010, a left deltoid intramuscular injection of FLUZONE (lot number UH181AB). Six hours after the vaccination on 21 September 2010, the patient "woke from sleeping" with burning eyes, chest pain and difficulty breathing. The patient had no illness at the time of the vaccination and received no vaccinations within 4 weeks. He had no pre-existing medical conditions and no concomitant medications. No other information was provided. The patient recovered on an unspecified date. Documents held by sender: None.
pt recvd vax; had fever; inc T of 105 approx 8 hrs p/ vax; fever down to 101 w/ acetaminophen;
severe myalgias at night and in am after vaccine, resulting in muscle cramping of hands and feet and "locking" of ankles and elbows. Upon waking in am was so impaired that she had to crawl to phone but regained mobility within 1/2 hour.  Function nl by 24 hours, Sx resolved by 36 hours
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 08-JUL-2015, the patient was inadvertently vaccinated with an expired dose of (Oka/Merck) VARIVAX (dose: 0.5 ml, route of administration: subcutaneous, lot# reported as J005690, expiry date 07-MAY-2015). There were no concomitant therapies reported. No adverse effects were reported. Additional information has been requested.
Itchy fingers, both hands.  Red.  No rash.  It occurred after the 1st dose too but thought it was a new soap that was then discontinued.  No treatment. Three weeks to subside.